277 related articles for article (PubMed ID: 19650968)
1. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.
Hung HS; Shyu WC; Tsai CH; Hsu SH; Lin SZ
Cell Transplant; 2009; 18(9):1003-12. PubMed ID: 19650968
[TBL] [Abstract][Full Text] [Related]
2. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.
Kawamoto A; Asahara T
Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361
[TBL] [Abstract][Full Text] [Related]
3. Endothelial progenitor cells as a new agent contributing to vascular repair.
Miller-Kasprzak E; Jagodziński PP
Arch Immunol Ther Exp (Warsz); 2007; 55(4):247-59. PubMed ID: 17659378
[TBL] [Abstract][Full Text] [Related]
4. Endothelial progenitor cells in cardiovascular disorders.
Shantsila E; Watson T; Lip GY
J Am Coll Cardiol; 2007 Feb; 49(7):741-52. PubMed ID: 17306702
[TBL] [Abstract][Full Text] [Related]
5. Endothelial progenitor cell-based neovascularization: implications for therapy.
Krenning G; van Luyn MJ; Harmsen MC
Trends Mol Med; 2009 Apr; 15(4):180-9. PubMed ID: 19303359
[TBL] [Abstract][Full Text] [Related]
6. Transfection of HGF gene enhances endothelial progenitor cell (EPC) function and improves EPC transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats.
Song MB; Yu XJ; Zhu GX; Chen JF; Zhao G; Huang L
Vascul Pharmacol; 2009; 51(2-3):205-13. PubMed ID: 19577663
[TBL] [Abstract][Full Text] [Related]
7. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
Marsboom G; Janssens S
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485
[TBL] [Abstract][Full Text] [Related]
8. In vivo enhancement of angiogenesis by adenoviral transfer of HIF-1alpha-modified endothelial progenitor cells (Ad-HIF-1alpha-modified EPC for angiogenesis).
Jiang M; Wang B; Wang C; He B; Fan H; Shao Q; Gao L; Liu Y; Yan G; Pu J
Int J Biochem Cell Biol; 2008; 40(10):2284-95. PubMed ID: 18450499
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.
Verma S; Kuliszewski MA; Li SH; Szmitko PE; Zucco L; Wang CH; Badiwala MV; Mickle DA; Weisel RD; Fedak PW; Stewart DJ; Kutryk MJ
Circulation; 2004 May; 109(17):2058-67. PubMed ID: 15078802
[TBL] [Abstract][Full Text] [Related]
10. Potential use of endothelial progenitor cells for regeneration of the vasculature.
Yamahara K; Itoh H
Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):17-27. PubMed ID: 19144668
[TBL] [Abstract][Full Text] [Related]
11. Endothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora's box?
Liew A; McDermott JH; Barry F; O'Brien T
Diabetes Obes Metab; 2008 May; 10(5):353-66. PubMed ID: 17825082
[TBL] [Abstract][Full Text] [Related]
12. Concise review: Circulating endothelial progenitor cells for vascular medicine.
Asahara T; Kawamoto A; Masuda H
Stem Cells; 2011 Nov; 29(11):1650-5. PubMed ID: 21948649
[TBL] [Abstract][Full Text] [Related]
13. Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials.
Ben-Shoshan J; George J
Pharmacol Ther; 2007 Jul; 115(1):25-36. PubMed ID: 17574679
[TBL] [Abstract][Full Text] [Related]
14. Endothelial progenitor cells for vasculogenesis.
Murasawa S; Asahara T
Physiology (Bethesda); 2005 Feb; 20():36-42. PubMed ID: 15653838
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of endothelial progenitor cells transferred by vascular endothelial growth factor gene for vascular regeneration of ischemic flaps.
Yi C; Xia W; Zheng Y; Zhang L; Shu M; Liang J; Han Y; Guo S
J Surg Res; 2006 Sep; 135(1):100-6. PubMed ID: 16566941
[TBL] [Abstract][Full Text] [Related]
16. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.
Sen S; McDonald SP; Coates PT; Bonder CS
Clin Sci (Lond); 2011 Apr; 120(7):263-83. PubMed ID: 21143202
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014
[TBL] [Abstract][Full Text] [Related]
18. Endothelial progenitor cells and cardiovascular cell-based therapies.
Mund JA; Ingram DA; Yoder MC; Case J
Cytotherapy; 2009; 11(2):103-13. PubMed ID: 19241233
[TBL] [Abstract][Full Text] [Related]
19. Vascular repair by endothelial progenitor cells.
Zampetaki A; Kirton JP; Xu Q
Cardiovasc Res; 2008 Jun; 78(3):413-21. PubMed ID: 18349136
[TBL] [Abstract][Full Text] [Related]
20. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue.
Duan H; Cheng L; Sun X; Wu Y; Hu L; Wang J; Zhao H; Lu G
Thromb Haemost; 2006 Dec; 96(6):807-15. PubMed ID: 17139377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
